|
US4436727A
(en)
|
1982-05-26 |
1984-03-13 |
Ribi Immunochem Research, Inc. |
Refined detoxified endotoxin product
|
|
US4866034A
(en)
|
1982-05-26 |
1989-09-12 |
Ribi Immunochem Research Inc. |
Refined detoxified endotoxin
|
|
US4987237A
(en)
|
1983-08-26 |
1991-01-22 |
Ribi Immunochem Research, Inc. |
Derivatives of monophosphoryl lipid A
|
|
US4877611A
(en)
|
1986-04-15 |
1989-10-31 |
Ribi Immunochem Research Inc. |
Vaccine containing tumor antigens and adjuvants
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
HU212924B
(en)
|
1989-05-25 |
1996-12-30 |
Chiron Corp |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
JPH0655749B2
(ja)
|
1989-09-20 |
1994-07-27 |
日本たばこ産業株式会社 |
リピッドａ単糖類縁体
|
|
US5370872A
(en)
|
1991-08-12 |
1994-12-06 |
Swiss Serum And Vaccine Institute Berne |
Escherichia coliO-polysaccharide-protein conjugate vaccine
|
|
US5593969A
(en)
|
1991-09-03 |
1997-01-14 |
Igen Incorporated |
Lipid-A analogs: monosaccharide and dissaccharide compounds for inhibiting binding of lipid A receptors to lipid A receptors
|
|
EP0761231B1
(en)
|
1992-06-25 |
2000-01-12 |
SMITHKLINE BEECHAM BIOLOGICALS s.a. |
Vaccine composition containing adjuvants
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
US6491919B2
(en)
|
1997-04-01 |
2002-12-10 |
Corixa Corporation |
Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
|
|
CA2284586C
(en)
|
1997-04-01 |
2011-02-08 |
Ribi Immunochem Research, Inc. |
Aqueous immunologic adjuvant compositions of monophosphoryl lipid a
|
|
US6500434B1
(en)
|
1998-04-23 |
2002-12-31 |
Medimmune, Inc. |
Chaperone and adhesin proteins; vaccines, diagnostics and method for treating infections
|
|
US6858211B1
(en)
|
1998-07-20 |
2005-02-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vaccines against Escherichia coli O157 infection
|
|
CZ301212B6
(cs)
|
1998-10-16 |
2009-12-09 |
Smithkline Beecham Biologicals S. A. |
Vakcinacní prostredek
|
|
WO2001025254A2
(en)
|
1999-10-04 |
2001-04-12 |
University Of Maryland Biotechnology Institute |
Novel adjuvant comprising a lipopolysaccharide antagonist
|
|
WO2001078777A2
(en)
|
2000-04-13 |
2001-10-25 |
Mossman, Sally |
Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and qs-21
|
|
JP2004502447A
(ja)
|
2000-07-07 |
2004-01-29 |
メディミューン，インコーポレイテッド |
ＦｉｍＨアドへシンタンパク質および使用方法
|
|
EP1313502A4
(en)
|
2000-08-18 |
2005-10-19 |
Medimmune Inc |
ADMINISTRATIVE PROCEDURE OF FIMH PROTEIN AS A VACCINE AGAINST HARNWAY INFECTIONS
|
|
WO2002102974A2
(en)
|
2000-12-08 |
2002-12-27 |
Medimmune, Inc. |
Mutant proteins, high potency inhibitory antibodies and fimch crystal structure
|
|
US6676958B2
(en)
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
|
CN101355928B
(zh)
|
2005-04-26 |
2013-05-22 |
卫材R&D管理株式会社 |
用于癌症免疫疗法的组合物和方法
|
|
JP5356807B2
(ja)
|
2005-05-11 |
2013-12-04 |
アイトヘネーシシェ テフニーシェ ホフシューレ チューリッヒ |
原核細胞由来の組み換えｎ−グリコシル化タンパク質
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
EP2007765B1
(en)
|
2006-03-23 |
2012-06-27 |
Novartis AG |
Immunopotentiating compounds
|
|
CA2646539A1
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Imidazoquinoxaline compounds as immunomodulators
|
|
HRP20181259T1
(hr)
|
2008-02-20 |
2018-10-05 |
Glaxosmithkline Biologicals S.A. |
Biokonjugati načinjeni iz rekombinantnih n-glikoziliranih proteina iz prokariotskih stanica
|
|
LT2437753T
(lt)
|
2009-06-05 |
2016-12-12 |
Infectious Disease Research Institute |
Sintetiniai gliukopiranozillipidų adjuvantai ir juos turinčios vakcinų kompozicijos
|
|
US11510875B2
(en)
|
2012-02-07 |
2022-11-29 |
Access To Advanced Health Institute |
Adjuvant formulations comprising TLR4 agonists and methods of using the same
|
|
PE20160080A1
(es)
|
2013-05-18 |
2016-02-21 |
Aduro Biotech Inc |
Composiciones y metodos para activar la senalizacion que depende del estimulador del gen de interferon
|
|
US9415097B2
(en)
|
2013-09-25 |
2016-08-16 |
Sequoia Sciences, Inc. |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9017698B2
(en)
|
2013-09-25 |
2015-04-28 |
Sequoia Sciences, Inc. |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9149521B2
(en)
|
2013-09-25 |
2015-10-06 |
Sequoia Sciences, Inc. |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9504743B2
(en)
|
2013-09-25 |
2016-11-29 |
Sequoia Sciences, Inc |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9415101B2
(en)
|
2013-09-25 |
2016-08-16 |
Sequoia Sciences, Inc. |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9149522B2
(en)
*
|
2013-09-25 |
2015-10-06 |
Sequoia Sciences, Inc. |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
EA035991B9
(ru)
|
2014-02-24 |
2020-10-21 |
Глаксосмитклайн Байолоджикалс С.А. |
Новый полисахарид и его применения
|
|
EP3693379A1
(en)
*
|
2015-05-13 |
2020-08-12 |
University of Washington |
Compositions and methods for treatment and prevention of uropathogenice. coli
|
|
EA039065B1
(ru)
|
2015-07-07 |
2021-11-29 |
Янссен Вэксинс Энд Превеншн Б.В. |
Вакцина против rsv
|
|
TWI715617B
(zh)
|
2015-08-24 |
2021-01-11 |
比利時商葛蘭素史密斯克藍生物品公司 |
對抗腸道外病原性大腸桿菌之免疫保護之方法及組合物
|
|
TW201946650A
(zh)
|
2018-03-12 |
2019-12-16 |
美商詹森藥物公司 |
針對腹內感染之疫苗
|
|
EP4077372A1
(en)
|
2019-12-20 |
2022-10-26 |
Vib Vzw |
Nanobody exchange chromatography
|
|
WO2021144369A1
(en)
|
2020-01-16 |
2021-07-22 |
Janssen Pharmaceuticals, Inc. |
Fimh mutant, compositions therewith and use thereof
|
|
TW202241929A
(zh)
|
2021-01-12 |
2022-11-01 |
美商詹森藥物公司 |
ＦｉｍＨ突變體、其組成物及其用途
|